GEOapplication/xmlftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE328nnn/GSE328236/primaryOK200TranscriptomicsMus musculusExpression profiling by high throughput sequencinghttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE328236GEOGSEfalseTranscriptomic profiling of Carfilzomib (CFZ) treatment in HSV-1 infected BV2 microglial cellsThis study investigates the molecular mechanisms underlying the interaction between Carfilzomib (CFZ) and Herpes Simplex Virus type 1 (HSV-1) infection in microglial cells. Using the BV2 microglial cell line, we performed RNA sequencing to dissect the transcriptional responses under different conditions. Cells were either infected with HSV-1 (MOI=1) for 24 hours or left uninfected, and subsequently treated with 30 nM Carfilzomib (CFZ) or the vehicle control (DMSO) 6 hours post infection.2026/04/21GSE328236GSM9675639GSM9675641GSM9675640GSM9675643GSM9675642GSM9675645GSM9675644GSM9675636GSM9675635GSM9675646GSM9675638GSM967563717021328236Mus musculus